Literature DB >> 697347

Activity of 5-episisomicin compared with that of other aminoglycosides.

K P Fu, H C Neu.   

Abstract

5-Episisomicin, a semisynthetic aminoglycoside, has been shown to inhibit many members of the Enterobacteriaceae, Pseudomonas aeruginosa, and Staphylococcus aureus. At a concentration of 3.1 mug/ml, more than 90% of Escherichia coli, Klebsiella pneumoniae, Enterobacter, Citrobacter, indole-positive Proteus, and Providencia were inhibited. 5-Episisomicin had activity against S. aureus, E. coli, Klebsiella, Enterobacter, and Citrobacter similar to gentamicin and netilmicin. It had activity similar to amikacin and netilmicin against many gentamicin-resistant bacteria. The activity of 5-episisomicin was greatest at an alkaline pH and in medium of low magnesium content. Synergy of 5-episisomicin and carbenicillin was found to occur most often against Pseudomonas.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 697347      PMCID: PMC352432          DOI: 10.1128/AAC.14.2.194

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Aminoglycoside-modifying enzymes.

Authors:  M J Haas; J E Dowding
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

Review 2.  Mechanisms of antibiotic resistance in bacteria.

Authors:  R Benveniste; J Davies
Journal:  Annu Rev Biochem       Date:  1973       Impact factor: 23.643

3.  Mutamicins; biosynthetically created new sisomicin analogues.

Authors:  R T Testa; G H Wagman; P J Daniels; M J Weinstein
Journal:  J Antibiot (Tokyo)       Date:  1974-12       Impact factor: 2.649

Review 4.  Tobramycin: an overview.

Authors:  H C Neu
Journal:  J Infect Dis       Date:  1976-08       Impact factor: 5.226

5.  Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside.

Authors:  J A Waitz; G H Miller; E Moss; P J Chiu
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

6.  In vitro study of netilmicin compared with other aminoglycosides.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

7.  In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

8.  Uptake of (methyl-14C)-sisomicin and (methyl-14C)-gentamicin into bacterial cells.

Authors:  B K Lee; R G Condon; H Munayyer; M J Weinstein
Journal:  J Antibiot (Tokyo)       Date:  1978-02       Impact factor: 2.649

  8 in total
  2 in total

1.  5-epi-Sisomicin and 5-epi-Gentamicin B: substrates for aminoglycoside-modifying enzymes that retain activity against aminoglycoside-resistant bacteria.

Authors:  A P Vastola; J Altschaefl; S Harford
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

2.  UK31214, a new aminoglycoside and derivative of kanamycin B.

Authors:  R Wise; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.